🕵️ Alzamend Neuro, Inc. ($ALZN)

SEC insider & ownership activity, last 12 months · CIK 1677077 · every row links its SEC filing

Over the last 12 months insiders sold $2.0M against $109K of open-market buying. Milton C. Ault III sold $2.0M (Jul–Apr). One red-flag 8-K in the window: Delisting notice (3.01), Mar 20, 2026.

Aug 2025: net +$0 Sep 2025: net -$649K Oct 2025: net -$936K Nov 2025: net +$0 Dec 2025: net -$11K Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$109K May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

1 buyer, $109K (1 lots) · 3 sellers, $2.0M (23 lots)

InsiderBuysBoughtSellsSoldLast
Milton C. Ault III1$109K 21$2.0MApr 14, 2026
William B. Horne0 1$7KDec 19, 2025
McGrath Lynne Fahey0 1$69Oct 23, 2025

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Other events (8.01)Jul 21, 2026 filing ↗
Financial Statements and Exhibits (9.01)Jul 21, 2026 filing ↗
Shareholder vote (5.07)Apr 17, 2026 filing ↗
Financial Statements and Exhibits (9.01)Apr 17, 2026 filing ↗
Delisting notice (3.01)Mar 20, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 20, 2026 filing ↗
Material agreement (1.01)Mar 6, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 6, 2026 filing ↗
Other events (8.01)Nov 18, 2025 filing ↗
Financial Statements and Exhibits (9.01)Nov 18, 2025 filing ↗
Charter/bylaw changes (5.03)Oct 14, 2025 filing ↗
Financial Statements and Exhibits (9.01)Oct 14, 2025 filing ↗
Unregistered equity sale (3.02)Oct 9, 2025 filing ↗
Financial Statements and Exhibits (9.01)Oct 9, 2025 filing ↗
Unregistered equity sale (3.02)Sep 25, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 25, 2025 filing ↗
Unregistered equity sale (3.02)Aug 1, 2025 filing ↗
Financial Statements and Exhibits (9.01)Aug 1, 2025 filing ↗